Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Nov 16, 2014; 2(11): 668-675
Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.668
Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.668
Figure 1 Suggested pathogenesis of idiopathic pulmonary fibrosis.
ROS: Reactive oxygen species; PDGF: Platelet-derived growth factor; TGF-β: Transforming growth factor beta; TNF-α: Tumor necrosis factor alpha; MMPs: Matrix metalloproteases; PAI: Platelet activator inhibitor; ECM: Extracellular matrix; TIMP: Tissue inhibitor of metalloproteases; FGF: Fibroblast growth factor; VEGF: Vascular endothelial growth factor.
- Citation: Sterclova M, Vasakova M. Promising new treatment targets in patients with fibrosing lung disorders. World J Clin Cases 2014; 2(11): 668-675
- URL: https://www.wjgnet.com/2307-8960/full/v2/i11/668.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i11.668